Cell Press and The Lancet titles now included in UC-Elsevier open access publishing agreement

Beginning September 1, 2022, UCLA corresponding authors publishing in Elsevier’s prestigious Cell Press and The Lancet journals will be able to publish their articles as open access with financial support from UCLA Library. Cell Press publishes 50 scientific journals in the life, physical, earth and health sciences. The Lancet is one of the world’s oldest and most prestigious medical journals.

When UC reached its landmark open access agreement with Elsevier in 2021, the full suite of journals published by Cell Press and The Lancet were not included. UC and Elsevier agreed that these high-cost journals would be phased in at a later date, once certain financial terms of the agreement were met. The inclusion of Cell Press and The Lancet titles adds to the 2,300 Elsevier journals that have been eligible for open access publishing support since the start of the agreement in 2021.

The agreement now enables corresponding UCLA authors to publish open access in Cell Press and The Lancet journals, regardless of whether they have research funds available to pay for open access publishing. All authors who choose to publish open access will receive a 10 percent discount on the open access fee (also known as an article processing charge, or APC), and the UCLA Library will automatically pay the first $1,000 of the APC. For authors who do not have funds available to pay the remainder, the Library will cover the full cost of the APC on their behalf, ensuring that lack of research funds does not present a barrier for UCLA authors who wish to publish open access.

For general details, please see the UC overview and FAQ of the Elsevier open access agreement.

If you are a UCLA corresponding author and have questions, please email UCLA Library Scholarly Communication at oa@library.ucla.edu.